CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion (Q43248975)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 8 January 2013

Language	Label	Description	Also known as
English	CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion	scientific article published on 8 January 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion (English)

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

author name string

Marie-Clare St Rose

1

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Roslyn A Taylor

2

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Suman Bandyopadhyay

3

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Harry Z Qui

4

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Adam T Hagymasi

5

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Anthony T Vella

6

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Adam J Adler

7

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

publication date

8 January 2013

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Immunology & Cell Biology

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

91

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

173-183

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Autocrine IFN-γ promotes naive CD8 T cell differentiation and synergizes with IFN-α to stimulate strong function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Breakdown in repression of IFN-γ mRNA leads to accumulation of self-reactive effector CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Cytotoxic CD4 T cells in antiviral immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

New insights on OX40 in the control of T cell immunity and immune tolerance in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Science gone translational: the OX40 agonist story

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

The initial phase of an immune response functions to activate regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Hypercostimulation through 4-1BB distorts homeostasis of immune cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Optimising anti-tumour CD8 T-cell responses using combinations of immunomodulatory antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Shaping and reshaping CD8+ T-cell memory.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

OX40 costimulation turns off Foxp3+ Tregs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Mechanisms of T cell tolerance and suppression in cancer mediated by tumor-associated antigens and hormones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

IL-2 regulates perforin and granzyme gene expression in CD8+ T cells independently of its effects on survival and proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

A function for interleukin 2 in Foxp3-expressing regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

TNF/TNFR family members in costimulation of T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

A novel transcription factor, T-bet, directs Th1 lineage commitment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

The multi-subunit interleukin-2 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

25 May 2018

IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

15 August 2018

IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

15 August 2018

OX40-mediated differentiation to effector function requires IL-2 receptor signaling but not CD28, CD40, IL-12Rbeta2, or T-bet.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

15 August 2018

IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

15 August 2018

4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

15 August 2018

Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

15 August 2018

A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

15 August 2018

The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570742

15 August 2018

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.74

21 January 2018

CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune response in mice that lack the interferon-gamma receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD8(+) T cell-mediated spontaneous diabetes in neonatal mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23295363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.74

7 January 2021

based on heuristic

inferred from DOI database lookup

Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.74

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/ICB.2012.74

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43248975&oldid=1984852915"